ATE214733T1 - Nachweissystem für die neurotrophin-aktivität - Google Patents

Nachweissystem für die neurotrophin-aktivität

Info

Publication number
ATE214733T1
ATE214733T1 AT92912036T AT92912036T ATE214733T1 AT E214733 T1 ATE214733 T1 AT E214733T1 AT 92912036 T AT92912036 T AT 92912036T AT 92912036 T AT92912036 T AT 92912036T AT E214733 T1 ATE214733 T1 AT E214733T1
Authority
AT
Austria
Prior art keywords
image
activity
neurotrophin
detection system
bdnf
Prior art date
Application number
AT92912036T
Other languages
English (en)
Inventor
Stephen P Squinto
David Glass
Thomas H Aldrich
Peter Distephano
Trevor Stitt
Mark E Furth
George D Yancopoulos
Peter C Maisonpierre
Piotr Masiakowski
Nancy Ip
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of ATE214733T1 publication Critical patent/ATE214733T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Saccharide Compounds (AREA)
AT92912036T 1991-04-23 1992-04-23 Nachweissystem für die neurotrophin-aktivität ATE214733T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69019991A 1991-04-23 1991-04-23
US73655991A 1991-07-26 1991-07-26
PCT/US1992/003376 WO1992018149A1 (en) 1991-04-23 1992-04-23 Assay systems for neurotrophin activity

Publications (1)

Publication Number Publication Date
ATE214733T1 true ATE214733T1 (de) 2002-04-15

Family

ID=27104557

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99203310T ATE336576T1 (de) 1991-04-23 1992-04-23 Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird
AT92912036T ATE214733T1 (de) 1991-04-23 1992-04-23 Nachweissystem für die neurotrophin-aktivität

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99203310T ATE336576T1 (de) 1991-04-23 1992-04-23 Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird

Country Status (18)

Country Link
EP (2) EP0589961B1 (de)
JP (1) JPH06509413A (de)
AT (2) ATE336576T1 (de)
AU (1) AU676664B2 (de)
CA (1) CA2109100A1 (de)
CZ (1) CZ223793A3 (de)
DE (2) DE69233649D1 (de)
DK (1) DK0589961T3 (de)
ES (1) ES2170056T3 (de)
FI (1) FI934701L (de)
HU (1) HUT66051A (de)
IE (1) IE921316A1 (de)
IL (1) IL101661A (de)
NO (1) NO933819L (de)
NZ (1) NZ242468A (de)
PT (1) PT100423A (de)
SK (1) SK116593A3 (de)
WO (1) WO1992018149A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109598A1 (en) * 1991-05-21 1992-11-26 Finn Hallbook Therapeutic and diagnostic methods based on neurotrophin-4- expression
WO1993025684A1 (en) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−３遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5625121A (en) * 1993-09-02 1997-04-29 Bristol-Myers Squibb Company Mice deficient in nerve growth factor receptors encoded by trkB
US5753225A (en) * 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
CZ310798A3 (cs) * 1996-03-28 1999-02-17 Trustees Of Boston University Způsob tlumení aktivace tyrosinasy, upravování pigmentace a identifikace látky, látka zesilující fosforylaci tyrosinasy, látka tlumící fosforylaci tyrosinasy, použití činidla tlumícího fosforylaci tyrosinasy, použití peptidu a použití DNA
WO1997037228A1 (en) 1996-03-29 1997-10-09 The Trustees Of Boston University Methods for diagnosing and treating alzheimer's disease
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
EP2789630A1 (de) 2013-04-09 2014-10-15 EngMab AG Bispezifische Antikörper gegen CD3e und ROR1
US11952421B2 (en) 2014-10-09 2024-04-09 Bristol-Myers Squibb Company Bispecific antibodies against CD3EPSILON and ROR1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US5231001A (en) * 1991-03-14 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
CA2062377A1 (en) * 1991-03-21 1992-09-22 Mariano Barbacid Method for detection of neuroactive substances
US5843749A (en) * 1991-07-26 1998-12-01 Regeneron Pharmaceuticals, Inc. Ehk and Ror tyrosine kinases

Also Published As

Publication number Publication date
IL101661A0 (en) 1992-12-30
IL101661A (en) 1998-02-08
HUT66051A (en) 1994-09-28
DK0589961T3 (da) 2002-05-27
SK116593A3 (en) 1994-11-09
IE921316A1 (en) 1992-11-04
EP1001024B1 (de) 2006-08-16
EP0589961A1 (de) 1994-04-06
EP1001024A3 (de) 2004-02-18
DE69232496D1 (de) 2002-04-25
FI934701A0 (fi) 1993-10-25
CA2109100A1 (en) 1992-10-29
EP0589961A4 (de) 1994-11-02
FI934701A7 (fi) 1993-12-22
JPH06509413A (ja) 1994-10-20
NZ242468A (en) 1994-12-22
DE69232496T2 (de) 2002-10-10
DE69233649D1 (de) 2006-09-28
EP1001024A2 (de) 2000-05-17
HU9303012D0 (en) 1994-03-28
AU676664B2 (en) 1997-03-20
EP0589961B1 (de) 2002-03-20
NO933819D0 (no) 1993-10-22
FI934701L (fi) 1993-12-22
NO933819L (no) 1993-12-20
WO1992018149A1 (en) 1992-10-29
CZ223793A3 (en) 1994-08-17
HK1024935A1 (en) 2000-10-27
ATE336576T1 (de) 2006-09-15
PT100423A (pt) 1993-08-31
ES2170056T3 (es) 2002-08-01
AU2014992A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
ATE214733T1 (de) Nachweissystem für die neurotrophin-aktivität
EP0727212A3 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
DK0842273T3 (da) Receptorligand VGEF-C
FI964862L (fi) FLT4-reseptorityrosiinikinaasi ja sen käyttö diagnostiikassa ja terapiassa
BR9611757A (pt) Derivados quinolino-4-carboxamida sua preparação e seu uso como antagonitas de receptor neuroquinina 3 (nk-3)-e neuroquinina 2 (nk-2)
WO1997021811A3 (en) Novel tyrosine kinase receptors and ligands
DE69023476D1 (de) Mehrschicht-Testvorrichtung zur Bestimmung von Substanzen in Flüssigkeiten.
DE69012485D1 (de) Zweispektrumsabbildung- und Falschfarben-Darstellungssystem.
DE69604228D1 (de) Pupillen Messanordnung und Alzheimer Krankheits Diagnosesystem
EP0886142A4 (de) Methode zur bestimmung von anti-gadii antikörpern und methode zur krebsdiagnose
DE69013072D1 (de) Gerät zur Analyse von Bestandteilen von Messflüssigkeiten.
FI925457A0 (fi) Receptor av den ciliaera neurotrofiska faktorn
ES2142317T3 (es) Polipeptidos de proteinas s y uso de los mismos.
DE69434498D1 (de) Denervierende muskelkinase (dmk), ein rezeptor der tyrosinkinase-superfamilie
CA2288080A1 (en) Method for the functional detection of disorders in the protein c system
EP0612355A4 (de) Nachweis von menschlicher p58-protein-kinase und ihrer dns zur diagnose von verschiedenen krebsarten.
FR2700829B1 (fr) Système d'analyse sous éclairage d'un document.
DE3886032D1 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
ATE148231T1 (de) Testsystem für degenerative muskelerkrankungen
FR2686704B1 (fr) Procede et systeme de test du fonctionnement et/ou de la presence d'elements connectes en parallele.
Suckow et al. Saliva and Plasma Desipramine
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
Derogis et al. Breath alcohol versus blood alcohol. 204 Cases in an emergency unit.
IT225224Z2 (it) Pedana estraibile composta da due gradini per campers e veicoli vari.
WO2000033073A3 (de) Detektionsverfahren für no im vollblut von säugern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee